John Henderson

John Henderson

Net worth: 6 M $ as of 31/05/2026

81 year
Health Technology
Commercial Services
Finance

Profile

John Tannahill Henderson is Chairman at Cytokinetics, Inc. since 2022, with employment at the firm starting in 2009.
Former roles include Chairman at Asmacure Ltée; Independent Director at Myriad Genetics, Inc. in 2020; Non-Executive Director at Inveresk Research Group, Inc.; Independent Director at Myrexis, Inc. from 2011 to 2013; Vice President at Pfizer Pharmaceuticals, Inc.; President at Futurepharm LLC; Chief Development Officer at NeuroVia, Inc.; and VP-Europe, US & International Pharmaceuticals at Pfizer Inc. Education includes undergraduate and doctorate degrees from The University of Edinburgh.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
27/05/2026 78,171 ( 0.06% ) 6 M $ 31/05/2026

John Henderson active positions

CompaniesPositionStart
CYTOKINETICS, INCORPORATED Chairman 08/04/2022

Former positions of John Henderson

CompaniesPositionEnd
MYRIAD GENETICS, INC. Chairman 23/03/2020
Corporate Officer/Principal 01/10/2018
MYREXIS, INC. Director/Board Member 01/01/2013
Corporate Officer/Principal 01/12/2000
PFIZER INC. Corporate Officer/Principal 01/12/2000
See the detail of John Henderson's experience

Training of John Henderson

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

48

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Health Technology

Commercial Services

Health Technology

Finance

Consumer Services

Health Technology

Health Technology

Futurepharm LLC

Health Technology

  1. Stock Market
  2. Insiders
  3. John Henderson